Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This compilation of articles elaborates on plant virus diseases that are among the most recent epidemiological concerns. The chapters explore several paradigms in plant virus epidemiology, outbreaks, epidemics, and pandemics paralleling zoonotic viruses and that can be consequential to global food security. There is evidence that the local, regional, national, and global trade of agricultural products has aided the global dispersal of plant virus diseases. Expanding farmlands into pristine natural areas has created opportunities for viruses in native landscapes to invade crops, while the movement of food and food products disseminates viruses, creating epidemics or pandemics. Moreover, plant virus outbreaks not only directly impact food supply, but also incidentally affect human health.

Research & information: general --- sugar beet --- rhizomania --- RNAseq --- virus --- necrovirus --- helper virus --- Aphis gossypii --- Cucumis melo --- cucurbit viruses --- disease progress curve --- insect trapping --- logistic model --- Spearman correlation --- temporal dynamics --- Bunyavirale --- RNA virus --- emerging virus --- virus evolution --- plant virus --- cophylogeny --- hallmark genes --- common bean --- Phaseolus vulgaris --- cytorhabdovirus --- whitefly --- Bemisia tabaci --- vector --- virus transmission --- ToTV --- emerging disease --- prevalence --- whole-genome sequencing --- phylogeny --- tomato torrado virus --- sGFP --- plant pathology --- infectious clone --- plant-virus interaction --- pandemics --- epidemics --- global --- disease --- threat --- food insecurity --- crop losses --- crop failure --- indigenous viruses --- introduced crops --- new encounter --- spillover --- developing countries --- domestication centers --- sub–Saharan Africa --- Potyviruses --- whole genome sequencing --- epidemiology --- virus resistance --- virus host interactions --- plant viruses --- viral vectors --- plant diseases --- virus spread --- biopharming --- vaccines --- viruses --- Nicotiana benthamiana --- COVID-19 --- plant-based biologics production --- n/a --- sub-Saharan Africa

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This compilation of articles elaborates on plant virus diseases that are among the most recent epidemiological concerns. The chapters explore several paradigms in plant virus epidemiology, outbreaks, epidemics, and pandemics paralleling zoonotic viruses and that can be consequential to global food security. There is evidence that the local, regional, national, and global trade of agricultural products has aided the global dispersal of plant virus diseases. Expanding farmlands into pristine natural areas has created opportunities for viruses in native landscapes to invade crops, while the movement of food and food products disseminates viruses, creating epidemics or pandemics. Moreover, plant virus outbreaks not only directly impact food supply, but also incidentally affect human health.

sugar beet --- rhizomania --- RNAseq --- virus --- necrovirus --- helper virus --- Aphis gossypii --- Cucumis melo --- cucurbit viruses --- disease progress curve --- insect trapping --- logistic model --- Spearman correlation --- temporal dynamics --- Bunyavirale --- RNA virus --- emerging virus --- virus evolution --- plant virus --- cophylogeny --- hallmark genes --- common bean --- Phaseolus vulgaris --- cytorhabdovirus --- whitefly --- Bemisia tabaci --- vector --- virus transmission --- ToTV --- emerging disease --- prevalence --- whole-genome sequencing --- phylogeny --- tomato torrado virus --- sGFP --- plant pathology --- infectious clone --- plant-virus interaction --- pandemics --- epidemics --- global --- disease --- threat --- food insecurity --- crop losses --- crop failure --- indigenous viruses --- introduced crops --- new encounter --- spillover --- developing countries --- domestication centers --- sub–Saharan Africa --- Potyviruses --- whole genome sequencing --- epidemiology --- virus resistance --- virus host interactions --- plant viruses --- viral vectors --- plant diseases --- virus spread --- biopharming --- vaccines --- viruses --- Nicotiana benthamiana --- COVID-19 --- plant-based biologics production --- n/a --- sub-Saharan Africa

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Foamy viruses, currently referred to as spumaretroviruses, are the most ancient retroviruses as evidenced by traces of viral sequences dispersed in all vertebrate classes from fish to mammals. Additionally, infectious foamy viruses circulate in a variety of mammalian species including simian, bovine, equine, caprine, and feline. Foamy viruses have many unique features which led to the division of the retrovirus family into two subfamilies, the Orthoretrovirinae and Spumaretrovirinae. In vitro, foamy viruses have a broad host range and in vivo, human infections have been described due to cross-species transmission from infected nonhuman primates. Thus far, there are no reports of virus-induced disease in humans or in the natural host species. These unique properties of foamy viruses have led researchers to develop foamy viruses as gene therapy vectors to study virus–virus and virus–host interactions for identifying factors involved in virus replication, transmission, and immune regulation that could influence potential clinical outcomes in humans as well as for using endogenous foamy virus sequences in the analysis of host species evolution.

Medicine --- Neurosciences --- spumavirus --- feline illness --- proviral load --- neglected virus --- bovine foamy virus --- infectious clone --- particle release --- cell-free transmission --- foamy virus --- spumaretrovirus --- cross-species virus transmission --- zoonosis --- restriction factors --- immune responses --- FV vectors --- virus replication --- latent infection --- feline foamy virus --- epidemiology --- retrovirus --- Spumaretrovirus --- mountain lion --- Puma concolor --- ELISA --- protease --- reverse transcriptase --- RNase H --- reverse transcription --- antiviral drugs --- resistance --- simian foamy virus --- gibbon --- lesser apes --- co-evolution --- complete viral genome --- equine foamy virus --- isolation --- Japan --- sero-epidemiology --- reptile foamy virus --- endogenous foamy virus --- endogenous retrovirus --- ancient retroviruses --- co-speciation --- foamy virus-host interactions --- viral tropism --- infection --- kidney --- cats --- chronic kidney disease --- chronic renal disease --- integrase --- integration --- co-infections --- NHP --- pathogenesis --- zoonoses --- viral prevalence --- Neotropical primates --- free-living primates --- Brazil --- new world primates --- simian retrovirus --- BFV --- spuma virus --- model system --- animal model --- animal experiment --- miRNA function --- gene expression --- antiviral host restriction --- gene therapy --- in-vivo gene therapy --- hematopoietic stem and progenitor cells --- foamy virus vector --- pre-clinical canine model --- SCID-X1 --- innate sensing --- cGAS --- STING --- foamy viruses --- wild ruminants --- European bison --- red deer --- roe deer --- fallow deer --- seroreactivity --- inter-species transmission --- HSC --- gene marking --- FV gene transfer to HSCs --- gene therapy alternatives --- serotype --- high-throughput sequencing --- replication kinetics --- cytopathic effect --- reverse transcriptase activity --- miRNA expression --- virus-host-interaction --- miRNA target gene identification --- innate immunity --- ANKRD17 --- Bif1 (SH3GLB1) --- replication in vitro

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family that historically has been associated with mild febrile illness. However, the recent outbreaks in Brazil in 2015 and its rapid spread throughout South and Central America and the Caribbean, together with its association with severe neurological disorders—including fetal microcephaly and Guillain-Barré syndrome in adults—have changed the historic perspective of ZIKV. Currently, ZIKV is considered an important public health concern that has the potential to affect millions of people worldwide. The significance of ZIKV in human health and the lack of approved vaccines and/or antiviral drugs to combat ZIKV infection have triggered a global effort to develop effective countermeasures to prevent and/or treat ZIKV infection. In this Special Issue of Viruses, we have assembled a collection of 32 research and review articles that cover the more recent advances on ZIKV molecular biology, replication and transmission, virus–host interactions, pathogenesis, epidemiology, vaccine development, antivirals, and viral diagnosis.

microRNAs --- antivirals --- reverse genetics --- nucleic acid computation --- viral pathogenesis --- plaque reduction neutralization test --- clinical trials --- viral genetic variation --- viral fitness --- pregnancy --- type I IFN antagonist --- prM-E proteins --- eye --- replicon --- antiviral responses --- Bacterial artificial chromosome --- gene expression --- NS1 protein --- viral permissiveness --- ZIKV–host interactions --- reporter virus --- viral persistence --- blood-retinal barrier --- virus like particles --- emerging arbovirus --- Non-human primates --- heme-oxygenase 1 --- mosquito surveillance --- antiviral compounds --- ZIKV-associated neurologic disorders --- external quality assessment --- outbreak control --- therapeutics --- cryptic promoter silencing --- testis --- neurons --- mutagenesis --- RNA-seq --- microsphere immunoassay --- host-directed antivirals --- molecular diagnostics --- Bayesian analyses --- astrocytomas --- Full-length cDNA infectious clones --- viral pathogenicity --- neural progenitor cells --- full-length molecular clone --- antiviral --- multiplex nucleic acid detection --- Asian-lineage --- nucleic acid strand exchange --- IgA --- African-lineage --- vaccines --- Zika --- research models and tools --- immune response --- IgG avidity tests --- polymerase chain reaction --- Asian lineage --- sexual transmission --- TLR7/8 --- neuropathogenesis --- cross-reactions --- genetic variability --- mosquito --- ZIKV --- infectious cDNA --- prostate --- host genetic variation --- monoclonal antibodies --- optimised --- anti-viral immunity --- QCMD --- arbovirus --- FSS13025 --- MR766 --- NS5 --- EQA --- testicular cells --- virus attachment --- flavivirus --- mosquito-borne flavivirus --- dsRNA --- boolean logic-processing nucleic acid probes --- Ziks virus --- viral replication --- Aedes aegypti --- infection --- natural history --- infectious RNA --- zika virus --- chimeric viruses --- subgenomic replicon --- replication --- human brain glial cells --- microglia cells --- hepatocytes --- bacterial artificial chromosome --- detoxification and immune system responses --- testes --- dengue viruses --- Zika virus --- insecticide resistance --- NS2A protein --- plasmid toxicity --- cell surface receptors --- serology --- viral evolution --- laboratory preparedness --- flaviviruses --- Tet-inducible --- dengue virus --- diagnosis --- assay standardization --- infectious clone --- ELISA --- innate response --- congenital Zika syndrome --- secondary infections --- apoptosis --- viral survival --- ocular --- validated --- rhesus macaques --- neuroinflammation --- placenta cells --- NHP --- Zika virus (ZIKV) --- point-of-care diagnostics --- isothermal nucleic acid amplification --- microcephaly --- cytopathic effects --- indirect immunofluorescence --- fetal infection --- therapy --- siRNA --- viral counteraction --- neural cells --- silvestrol --- eIF4A

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family that historically has been associated with mild febrile illness. However, the recent outbreaks in Brazil in 2015 and its rapid spread throughout South and Central America and the Caribbean, together with its association with severe neurological disorders—including fetal microcephaly and Guillain-Barré syndrome in adults—have changed the historic perspective of ZIKV. Currently, ZIKV is considered an important public health concern that has the potential to affect millions of people worldwide. The significance of ZIKV in human health and the lack of approved vaccines and/or antiviral drugs to combat ZIKV infection have triggered a global effort to develop effective countermeasures to prevent and/or treat ZIKV infection. In this Special Issue of Viruses, we have assembled a collection of 32 research and review articles that cover the more recent advances on ZIKV molecular biology, replication and transmission, virus–host interactions, pathogenesis, epidemiology, vaccine development, antivirals, and viral diagnosis.

microRNAs --- antivirals --- reverse genetics --- nucleic acid computation --- viral pathogenesis --- plaque reduction neutralization test --- clinical trials --- viral genetic variation --- viral fitness --- pregnancy --- type I IFN antagonist --- prM-E proteins --- eye --- replicon --- antiviral responses --- Bacterial artificial chromosome --- gene expression --- NS1 protein --- viral permissiveness --- ZIKV–host interactions --- reporter virus --- viral persistence --- blood-retinal barrier --- virus like particles --- emerging arbovirus --- Non-human primates --- heme-oxygenase 1 --- mosquito surveillance --- antiviral compounds --- ZIKV-associated neurologic disorders --- external quality assessment --- outbreak control --- therapeutics --- cryptic promoter silencing --- testis --- neurons --- mutagenesis --- RNA-seq --- microsphere immunoassay --- host-directed antivirals --- molecular diagnostics --- Bayesian analyses --- astrocytomas --- Full-length cDNA infectious clones --- viral pathogenicity --- neural progenitor cells --- full-length molecular clone --- antiviral --- multiplex nucleic acid detection --- Asian-lineage --- nucleic acid strand exchange --- IgA --- African-lineage --- vaccines --- Zika --- research models and tools --- immune response --- IgG avidity tests --- polymerase chain reaction --- Asian lineage --- sexual transmission --- TLR7/8 --- neuropathogenesis --- cross-reactions --- genetic variability --- mosquito --- ZIKV --- infectious cDNA --- prostate --- host genetic variation --- monoclonal antibodies --- optimised --- anti-viral immunity --- QCMD --- arbovirus --- FSS13025 --- MR766 --- NS5 --- EQA --- testicular cells --- virus attachment --- flavivirus --- mosquito-borne flavivirus --- dsRNA --- boolean logic-processing nucleic acid probes --- Ziks virus --- viral replication --- Aedes aegypti --- infection --- natural history --- infectious RNA --- zika virus --- chimeric viruses --- subgenomic replicon --- replication --- human brain glial cells --- microglia cells --- hepatocytes --- bacterial artificial chromosome --- detoxification and immune system responses --- testes --- dengue viruses --- Zika virus --- insecticide resistance --- NS2A protein --- plasmid toxicity --- cell surface receptors --- serology --- viral evolution --- laboratory preparedness --- flaviviruses --- Tet-inducible --- dengue virus --- diagnosis --- assay standardization --- infectious clone --- ELISA --- innate response --- congenital Zika syndrome --- secondary infections --- apoptosis --- viral survival --- ocular --- validated --- rhesus macaques --- neuroinflammation --- placenta cells --- NHP --- Zika virus (ZIKV) --- point-of-care diagnostics --- isothermal nucleic acid amplification --- microcephaly --- cytopathic effects --- indirect immunofluorescence --- fetal infection --- therapy --- siRNA --- viral counteraction --- neural cells --- silvestrol --- eIF4A